[Actual problems in clinical chemotherapy].
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D004751:Enteritis / Q000188:drug therapy; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D008034:Lincomycin / Q000627:therapeutic use; D008581:Meningitis / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D002511:Cephalosporins; D005839:Gentamicins; D010406:Penicillins; D013449:Sulfonamides; D014640:Vancomycin; D008034:Lincomycin; D012293:Rifampin
Aktuelle Probleme der klinischen Chemotherapie.